Inventor

HAN BINGSONG

US76 patents

⚠️ This page may combine multiple inventors who share the name “HAN BINGSONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAN BINGSONG

FORMA THERAPEUTICS INC

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors

3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

VALO HEALTH INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Methods using HDAC11 inhibitors

Compounds and compositions for the inhibition of NAMPT

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

VALO EARLY DISCOVERY INC

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

[6,6] fused bicyclic HDAC8 inhibitors

FORMA TM LLC

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

BAIR KENNETH W

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)

NOVO NORDISK HEALTHCARE AG

Treating sickle cell disease with a pyruvate kinase R activating compound